Ken Morii

994 total citations
54 papers, 742 citations indexed

About

Ken Morii is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Ken Morii has authored 54 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Neurology and 11 papers in Genetics. Recurrent topics in Ken Morii's work include Glioma Diagnosis and Treatment (10 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Ken Morii is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Ken Morii collaborates with scholars based in Japan and United States. Ken Morii's co-authors include Seiichi Yoshida, Reina Tanaka, Ryuichi Tanaka, Toshiro Kumanishi, Masato Watanabe, Kazuo Washiyama, Takafumi Saito, Itaru Tsumanuma, Yasuo Takahashi and Ryozo Kuwano and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Genome Research and Journal of neurosurgery.

In The Last Decade

Ken Morii

52 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Morii Japan 17 233 220 147 145 117 54 742
Shigeaki Hori Japan 19 193 0.8× 136 0.6× 290 2.0× 103 0.7× 143 1.2× 41 875
Takafumi Ide Japan 14 281 1.2× 237 1.1× 256 1.7× 146 1.0× 120 1.0× 33 797
Toru Iwaki Japan 14 300 1.3× 101 0.5× 191 1.3× 120 0.8× 146 1.2× 20 863
Anna Maria Buccoliero Italy 17 271 1.2× 267 1.2× 197 1.3× 141 1.0× 95 0.8× 86 860
Shunji Yunoue Japan 16 237 1.0× 190 0.9× 175 1.2× 81 0.6× 124 1.1× 26 733
Tomoyuki Koga Japan 20 266 1.1× 269 1.2× 414 2.8× 134 0.9× 111 0.9× 61 1.1k
Naoko Sanno Japan 25 382 1.6× 269 1.2× 195 1.3× 70 0.5× 398 3.4× 77 1.6k
E. T. Hedley‐Whyte United States 16 418 1.8× 364 1.7× 367 2.5× 74 0.5× 150 1.3× 28 1.2k
Michael Tobias United States 12 320 1.4× 223 1.0× 171 1.2× 76 0.5× 130 1.1× 30 777
Carlos Salvador Spain 20 517 2.2× 311 1.4× 303 2.1× 128 0.9× 85 0.7× 39 1.3k

Countries citing papers authored by Ken Morii

Since Specialization
Citations

This map shows the geographic impact of Ken Morii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Morii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Morii more than expected).

Fields of papers citing papers by Ken Morii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Morii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Morii. The network helps show where Ken Morii may publish in the future.

Co-authorship network of co-authors of Ken Morii

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Morii. A scholar is included among the top collaborators of Ken Morii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Morii. Ken Morii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yamanaka, Ryuya, Ken Morii, Yoko Shinbo, et al.. (2008). Results of Treatment of 112 Cases of Primary CNS Lymphoma. Japanese Journal of Clinical Oncology. 38(5). 373–380. 17 indexed citations
3.
Yoshida, Seiichi & Ken Morii. (2005). Intrathecal chemotherapy for patients with meningeal carcinomatosis. Surgical Neurology. 63(1). 52–55. 20 indexed citations
4.
Yoshida, Seiichi & Ken Morii. (2004). The role of surgery in the treatment of brain metastasis: a retrospective review. Acta Neurochirurgica. 146(8). 767–70. 10 indexed citations
5.
Morii, Ken, et al.. (2003). In situ Hybridization Analysis of Neuronatin mRNA in the Human Pituitary Gland and Pituitary Tumors. 51(1). 25–30. 1 indexed citations
6.
Inenaga, Chikanori, et al.. (2003). Mesenchymal chondrosarcoma of the sellar region. Acta Neurochirurgica. 145(7). 593–597. 14 indexed citations
7.
Morii, Ken, et al.. (2002). A Critical Pneumonia by Multidrug-resistant Enterococcus faecium in a Chronic Hemodialysis Patient. A case report. Kansenshogaku zasshi. 76(12). 1035–1039. 2 indexed citations
8.
Morii, Ken, et al.. (2001). Neurohypophyseal germinoma traced from its earliest stage via magnetic resonance imaging: case report. Surgical Neurology. 56(4). 236–241. 13 indexed citations
9.
Yoshida, Seiichi, Ken Morii, Masato Watanabe, et al.. (2001). The generation of anti-tumoral cells using dendritic cells from the peripheral blood of patients with malignant brain tumors. Cancer Immunology Immunotherapy. 50(6). 321–327. 23 indexed citations
10.
Yoshida, Seiichi & Ken Morii. (2000). Serum concentrations of soluble interleukin-2 receptor in patients with malignant brain tumors. Journal of Surgical Oncology. 75(2). 131–135. 11 indexed citations
11.
Yoshida, Seiichi, Ken Morii, Masato Watanabe, & Takafumi Saito. (2000). Characteristic features of malignant lymphoma with central nervous system involvement. Surgical Neurology. 53(2). 163–167. 25 indexed citations
12.
Morii, Ken, et al.. (1997). Expression of Telomerase RNA, Telomerase Activity, and Telomere Length in Human Gliomas. Biochemical and Biophysical Research Communications. 239(3). 830–834. 27 indexed citations
13.
Macina, Roberto A., et al.. (1995). Molecular cloning and RARE cleavage mapping of human 2p, 6q, 8q, 12q, and 18q telomeres.. Genome Research. 5(3). 225–232. 23 indexed citations
14.
Muratake, Tatsuyuki, Shigenobu Hayashi, Ken Morii, et al.. (1995). The effect of methamphetamine on the mRNA level for 14·3·3 ⥈ chain in the human cultured cells. Molecular Neurobiology. 11(1-3). 223–230. 9 indexed citations
15.
Tanaka, Junji, Masaharu Kasai, Masahiro Imamura, et al.. (1994). Evaluation of mixed chimaerism and origin of bone marrow derived fibroblastoid cells after allogeneic bone marrow transplantation. British Journal of Haematology. 86(2). 436–438. 26 indexed citations
16.
Tanaka, Junji, Masahiro Imamura, Masaharu Kasai, et al.. (1993). Cytokine gene expression in peripheral blood mononuclear cells during graft‐versus‐host disease after allogeneic bone marrow transplantation. British Journal of Haematology. 85(3). 558–565. 53 indexed citations
17.
Morii, Ken, Shigenobu Hayashi, Satoshi Minoshima, et al.. (1992). Structure and expression of human and rat D2 dopamine receptor genes. Neurochemistry International. 21(1). 91–98. 16 indexed citations
18.
Tanaka, Junji, M Kasai, Nobuo Masauzi, et al.. (1992). Successful second allogeneic bone marrow transplantation in a relapsed acute myeloid leukemia patient with fungal liver abscess. Annals of Hematology. 65(4). 193–195. 3 indexed citations
19.
Togashi, Hiroko, et al.. (1990). Simultaneous high-performance liquid chromatographic determination of norepinephrine, serotonin, acetylcholine and their metabolites in the cerebrospinal fluid of anaesthetized normotensive rats. Journal of Chromatography B Biomedical Sciences and Applications. 526(1). 1–10. 24 indexed citations
20.
Koda, Kyuhei, Katsumi Morita, Takeshi Matsunaga, et al.. (1990). [Combination chemotherapy of UFT with adriamycin (ADM) and cisplatin (CDDP) for advanced gastrointestinal cancer].. PubMed. 17(9). 1893–900. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026